These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 24870978)

  • 1. The receptor for advanced glycation end-products (RAGE) plays a key role in the formation of nanotubes (NTs) between peritoneal mesothelial cells and in murine kidneys.
    Ranzinger J; Rustom A; Heide D; Morath C; Schemmer P; Nawroth PP; Zeier M; Schwenger V
    Cell Tissue Res; 2014 Sep; 357(3):667-79. PubMed ID: 24870978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling.
    Liu J; Huang K; Cai GY; Chen XM; Yang JR; Lin LR; Yang J; Huo BG; Zhan J; He YN
    Cell Signal; 2014 Jan; 26(1):110-21. PubMed ID: 24113348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myofibroblast transdifferentiation of mesothelial cells is mediated by RAGE and contributes to peritoneal fibrosis in uraemia.
    De Vriese AS; Tilton RG; Mortier S; Lameire NH
    Nephrol Dial Transplant; 2006 Sep; 21(9):2549-55. PubMed ID: 16757496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of receptors for advanced glycation end-products in peritoneal mesothelial cells exposed to glucose degradation products.
    Lai KN; Leung JC; Chan LY; Li FF; Tang SC; Lam MF; Tse KC; Yip TP; Chan TM; Wieslander A; Vlassara H
    Clin Exp Immunol; 2004 Dec; 138(3):466-75. PubMed ID: 15544624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of receptor for advanced glycation end product attenuates pulmonary reperfusion injury in mice.
    Sternberg DI; Gowda R; Mehra D; Qu W; Weinberg A; Twaddell W; Sarkar J; Wallace A; Hudson B; D'Ovidio F; Arcasoy S; Ramasamy R; D'Armiento J; Schmidt AM; Sonett JR
    J Thorac Cardiovasc Surg; 2008 Dec; 136(6):1576-85. PubMed ID: 19114209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
    Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A9 promotes human hepatocellular carcinoma cell growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK pathways.
    Wu R; Duan L; Cui F; Cao J; Xiang Y; Tang Y; Zhou L
    Exp Cell Res; 2015 Jun; 334(2):228-38. PubMed ID: 25907296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.
    Zeng S; Feirt N; Goldstein M; Guarrera J; Ippagunta N; Ekong U; Dun H; Lu Y; Qu W; Schmidt AM; Emond JC
    Hepatology; 2004 Feb; 39(2):422-32. PubMed ID: 14767995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor for advanced glycation end product (RAGE)-dependent modulation of early growth response-1 in hepatic ischemia/reperfusion injury.
    Zeng S; Dun H; Ippagunta N; Rosario R; Zhang QY; Lefkowitch J; Yan SF; Schmidt AM; Emond JC
    J Hepatol; 2009 May; 50(5):929-36. PubMed ID: 19303658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-mobility group box-1 in ischemia-reperfusion injury of the heart.
    Andrassy M; Volz HC; Igwe JC; Funke B; Eichberger SN; Kaya Z; Buss S; Autschbach F; Pleger ST; Lukic IK; Bea F; Hardt SE; Humpert PM; Bianchi ME; Mairbäurl H; Nawroth PP; Remppis A; Katus HA; Bierhaus A
    Circulation; 2008 Jun; 117(25):3216-26. PubMed ID: 18574060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin.
    Mahajan N; Bahl A; Dhawan V
    Int J Cardiol; 2010 Jul; 142(3):273-8. PubMed ID: 19201044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits advanced glycation end products (AGEs)-induced renal tubular cell injury by suppressing reactive oxygen species generation via reducing receptor for AGEs (RAGE) expression.
    Ishibashi Y; Matsui T; Takeuchi M; Yamagishi S
    Horm Metab Res; 2012 Nov; 44(12):891-5. PubMed ID: 22864903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury.
    Ben Mkaddem S; Pedruzzi E; Werts C; Coant N; Bens M; Cluzeaud F; Goujon JM; Ogier-Denis E; Vandewalle A
    Cell Death Differ; 2010 Sep; 17(9):1474-85. PubMed ID: 20224597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end-products activate extracellular signal-regulated kinase via the oxidative stress-EGF receptor pathway in renal fibroblasts.
    Chen SC; Guh JY; Hwang CC; Chiou SJ; Lin TD; Ko YM; Huang JS; Yang YL; Chuang LY
    J Cell Biochem; 2010 Jan; 109(1):38-48. PubMed ID: 19885844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAGE mediates vascular injury and inflammation after global cerebral ischemia.
    Kamide T; Kitao Y; Takeichi T; Okada A; Mohri H; Schmidt AM; Kawano T; Munesue S; Yamamoto Y; Yamamoto H; Hamada J; Hori O
    Neurochem Int; 2012 Feb; 60(3):220-8. PubMed ID: 22202666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of receptor for advanced glycation end products by insufficient leptin action triggers pancreatic β-cell failure in type 2 diabetes.
    Han D; Yamamoto Y; Munesue S; Motoyoshi S; Saito H; Win MT; Watanabe T; Tsuneyama K; Yamamoto H
    Genes Cells; 2013 Apr; 18(4):302-14. PubMed ID: 23410183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-κB signaling.
    Volz HC; Laohachewin D; Seidel C; Lasitschka F; Keilbach K; Wienbrandt AR; Andrassy J; Bierhaus A; Kaya Z; Katus HA; Andrassy M
    Basic Res Cardiol; 2012 Mar; 107(2):250. PubMed ID: 22318783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.
    Schwenger V; Morath C; Salava A; Amann K; Seregin Y; Deppisch R; Ritz E; Bierhaus A; Nawroth PP; Zeier M
    J Am Soc Nephrol; 2006 Jan; 17(1):199-207. PubMed ID: 16319192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for advanced glycation end products facilitates host defense during Escherichia coli-induced abdominal sepsis in mice.
    van Zoelen MA; Schmidt AM; Florquin S; Meijers JC; de Beer R; de Vos AF; Nawroth PP; Bierhaus A; van der Poll T
    J Infect Dis; 2009 Sep; 200(5):765-73. PubMed ID: 19627249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury.
    Bucciarelli LG; Kaneko M; Ananthakrishnan R; Harja E; Lee LK; Hwang YC; Lerner S; Bakr S; Li Q; Lu Y; Song F; Qu W; Gomez T; Zou YS; Yan SF; Schmidt AM; Ramasamy R
    Circulation; 2006 Mar; 113(9):1226-34. PubMed ID: 16505177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.